To save researchers time and resources, The Michael J. Fox Foundation has made a number of tools available to the scientific community at low cost, with rapid delivery.
Helpful Resources
-
Sponsored Tools Program
Learn more about how MJFF can help share your tools.
-
Tools Consortium
MJFF is working with industry to develop priority tools.
-
Preclinical Models
Learn more about the various in vivo models used in Parkinson's disease research.
Find a Research Tool
Filter by Tool Type or Gene/Protein Type to Organize Results
* = MJFF does not control pricing or terms of availability for this tool.
-
INPP5F Antibody
Rabbit monoclonal antibody directed against human/mouse INPP5F for immunoblotting and immunostaining applications.
Estimated Availability: Early 2025
-
TMEM175 Antibody
Rabbit monoclonal antibody directed against human/mouse TMEM175 for immunoblotting and immunostaining applications.
Estimated Availability: Early 2025
-
ATP10B Antibody
Rabbit monoclonal antibody directed against human/mouse ATP10B for immunoblotting and immunostaining applications.
Estimated Availability: Early 2025
-
ATP13A2 Antibody
Rabbit monoclonal antibody directed against human ATP13A2 for immunoblotting, immunostaining, and immunoprecipitation applications.
Estimated Availability: Early 2026
-
TMEM192 Antibody
Rabbit monoclonal antibody directed against human/mouse TMEM192 for immunoprecipitation of endogenous lysosomes.
Estimated Availability: Late 2025
-
OMP25 Antibody
Rabbit monoclonal antibody directed against human/mouse OMP25 for immunoprecipitation of endogenous mitochondria.
Estimated Availability: Late 2025
-
TMEM115 Antibody
Rabbit monoclonal antibody directed against human/mouse TMEM115 for immunoprecipitation of endogenous golgi.
Estimated Availability: Mid 2026
-
ATP10B Knockout Cell Line
Cell with homozygous knockout of APT10B.
Estimated Availability: Late 2024
Have questions or need additional information?
Email tools@michaeljfox.org with questions and to suggest new tools for us to develop. Or visit our FAQ page.
"We have shown, thanks in part to MJFF, that researchers now have in their pantry the right ‘ingredients’, to... help to drive forward PD drug development.”
Heather Melrose, PhD
Mayo Clinic